Company Filing History:
Years Active: 2021
Title: Innovator Spotlight: Rebekka Kubisch-Dohmen in Munich, Germany
Introduction
Rebekka Kubisch-Dohmen, an accomplished inventor based in Munich, Germany, has made significant strides in the field of biotechnology. With a focus on innovative solutions, she has secured two patents that showcase her expertise and dedication to advancing scientific knowledge.
Latest Patents
Rebekka's latest patents include groundbreaking work on Ornithine transcarbamylase coding polyribonucleotides and formulations thereof. This patent relates to compositions that comprise modified Ornithine transcarbamylase (OTC) polyribonucleotides and methods for their use. Additionally, she has developed a patent on Cas9 mRNAs, which involves compositions comprising modified Cas9 polyribonucleotides and methods of use, as well as Cas9 polynucleotides and polyribonucleotides. These innovations highlight her contributions to crucial advancements in genetic engineering.
Career Highlights
Rebekka is currently a key team member at Ethris GmbH, where she applies her expertise in biotechnology to develop novel therapeutic solutions. Her work at Ethris not only reflects her innovative mindset but also her commitment to transforming the landscape of modern medicine.
Collaborations
Throughout her career, Rebekka has collaborated with talented colleagues, including Carsten Rudolph and Manish Kumar Aneja. These partnerships have played a vital role in her research endeavors and have contributed to her success in obtaining patents.
Conclusion
Rebekka Kubisch-Dohmen is a notable figure in the world of biotechnology. Her ingenious patents and collaborative spirit position her as a valuable innovator in her field. As she continues her work at Ethris GmbH, her contributions are sure to inspire future breakthroughs in scientific research and applications.